Baird raised the firm’s price target on Labcorp (LH) to $302 from $290 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Labcorp price target raised to $306 from $283 at Morgan Stanley
- Positive Outlook for Labcorp Holdings: Buy Rating Justified by Strong Future Prospects and Strategic Growth Initiatives
- Labcorp Reports Strong Q2 2025 Results, Raises Guidance
- Labcorp Holdings Reports Strong Growth and Raises Guidance
- Labcorp Holdings: Strong Financial Performance and Promising Outlook Justify Buy Rating